Allplex SARS CoV-2 FluA/FluB/RSV Assay is a multiplex real-time PCR assay designed to facilitate simultaneous amplification and differentiation of respiratory symptoms
Seegene’s multiplex assay has secured Health Canada approval under Interim Order. (Credit: Gerd Altmann from Pixabay)
Molecular diagnostic company Seegene has secured approval from the Health Canada for its Allplex SARS CoV-2 FluA/FluB/RSV assay under the regulator’s Interim Order.
Allplex SARS CoV-2 FluA/FluB/RSV Assay is a multiplex real-time PCR assay designed to facilitate simultaneous amplification and differentiation of respiratory symptoms.
It holds the potential to differentiate Influenza A, B, RSV, and Covid-19 in a single test.
Seegene stated that the assay is expected to play a significant role in responding against the potential twindemic as the country is forecasting a surge in both flu patients and Covid-19 patients.
On 13 January, Seegene supplied 340,000 Covid-19 tests to Canada to meet increasing demand for Covid-19 tests.
Seegene chief sales and marketing officer Ho Yi said: “Demand for Covid-19 tests is skyrocketing due to the resurgence of confirmed cases.
“We are fully prepared to supply enough test kits globally and will continue to be strong global partners in the effort to manage the spread of Covid-19.”
Seegene has also announced delivering over five million Covid-19 tests to Israel to help detect and mitigate the spread of the Omicron variant.
It is also expected to supply various products to Israel, including its Allplex SARS-CoV-2 Master Assay and Allplex SARS CoV-2 FluA/FluB/RSV Assay.
In February last year, the company announced the development of Allplex SARS-CoV-2 Variants Ⅰ Assay, which is claimed to be the world’s first Covid-19 diagnostic variant test.
The Allplex SARS-CoV-2 Variants Ⅰ Assay has the potential to screen and detect multiple mutant variations, including contagious and fatal, in a single reaction.
Seegene, an in-vitro diagnostics (IVD) company, manages subsidiaries in the US, Canada, Germany, Italy, Mexico, Brazil, Colombia, and the Middle East.